Clinical Study
Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma
Table 7
Sentinel Lymph Node Biopsy (SLNB).
| | Yes | No |
| SLNB | 48 (86%) | 6 (11%) | Positive SLNB | 23 (48%) | 25 (52%) | Positive SLN and a positive node on PET/CT | 6 (26%) | 17 (74%) |
|
|